⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SBFM News
Sunshine Biopharma Inc.
Form 8-K
sec.gov
SBFMW
SBFM
Form 8-K
sec.gov
SBFMW
SBFM
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
accessnewswire.com
SBFM
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
accessnewswire.com
SBFM
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
accessnewswire.com
SBFM
Form 8-K
sec.gov
SBFM
SBFMW